Onabotulinumtoxina
Brand name: Botox
Rank #306 of 500 drugs by total cost
$37.0M
Total Cost
25,440
Total Claims
$37.0M
Total Cost
767
Prescribers
$1,455
Cost per Claim
7,373
Beneficiaries
71,757
30-Day Fills
$48K
Avg Cost/Provider
33
Avg Claims/Provider
About Onabotulinumtoxina
Onabotulinumtoxina (sold as Botox) was prescribed 25,440 times by 767 Medicare Part D providers in 2023, costing the program $37.0M. At $1,455 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 303 | Risperidone (Risperidone) | $37.4M | 1,480,207 |
| 304 | Prednisone (Prednisone) | $37.3M | 5,970,737 |
| 305 | Tacrolimus (Tacrolimus) | $37.1M | 175,053 |
| 306 | Onabotulinumtoxina (Botox) | $37.0M | 25,440 |
| 307 | Azelastine Hcl (Azelastine Hcl) | $36.6M | 996,341 |
| 308 | Tizanidine Hcl (Tizanidine Hcl) | $36.5M | 2,602,362 |
| 309 | Fentanyl (Fentanyl) | $36.2M | 324,419 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology